James A. Bianco (Cell Therapeutics Inc. (CTI))

Bianco, James A. (Cell Therapeutics 200510 CEO)

	Organisation	Cell Therapeutics Inc. (CTI)
	Group	Cell Therapeutics (Group)

Record changed: 2017-04-09

More documents for James A. Bianco

[1] Cell Therapeutics, Inc.. (2/17/12). "Press Release: European Medicines Agency’s Committee for Medicinal Products for Human Use Issues Positive Opinion for Conditional Approval on Marketing Authorization Application for Pixuvri". Seattle, WA....
[2] Cell Therapeutics, Inc.. (1/3/12). "Press Release: FDA’s Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012". Seattle, WA....
[3] Cell Therapeutics, Inc.. (12/19/11). "Press Release: Retires Remaining Convertible Debt. Deleveraged Balance Sheet Provides Stronger Financial Posititon as Company Looks Forward to Potential Prodcut Approval in 2012". Seattle, WA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

James A. Bianco (Cell Therapeutics Inc. (CTI))

More documents for James A. Bianco